Logo image of MAMA

MAMA'S CREATIONS INC (MAMA) Stock Fundamental Analysis

NASDAQ:MAMA - Nasdaq - US56146T1034 - Common Stock - Currency: USD

8.3  +0.08 (+0.97%)

After market: 8.3 0 (0%)

Fundamental Rating

5

Overall MAMA gets a fundamental rating of 5 out of 10. We evaluated MAMA against 91 industry peers in the Food Products industry. MAMA has an average financial health and profitability rating. MAMA is valued quite expensive, but it does show an excellent growth. These ratings would make MAMA suitable for growth investing!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MAMA had positive earnings in the past year.
MAMA had a positive operating cash flow in the past year.
MAMA had positive earnings in 4 of the past 5 years.
Each year in the past 5 years MAMA had a positive operating cash flow.
MAMA Yearly Net Income VS EBIT VS OCF VS FCFMAMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

1.2 Ratios

MAMA has a Return On Assets of 8.34%. This is amongst the best in the industry. MAMA outperforms 84.62% of its industry peers.
With an excellent Return On Equity value of 16.62%, MAMA belongs to the best of the industry, outperforming 86.81% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 12.98%, MAMA belongs to the top of the industry, outperforming 91.21% of the companies in the same industry.
Industry RankSector Rank
ROA 8.34%
ROE 16.62%
ROIC 12.98%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MAMA Yearly ROA, ROE, ROICMAMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200 -200 -400

1.3 Margins

Looking at the Profit Margin, with a value of 3.41%, MAMA is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
MAMA's Profit Margin has declined in the last couple of years.
The Operating Margin of MAMA (4.41%) is comparable to the rest of the industry.
MAMA's Operating Margin has declined in the last couple of years.
MAMA has a Gross Margin (24.39%) which is comparable to the rest of the industry.
MAMA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.41%
PM (TTM) 3.41%
GM 24.39%
OM growth 3Y185.5%
OM growth 5Y-8.49%
PM growth 3YN/A
PM growth 5Y-7.87%
GM growth 3Y0.31%
GM growth 5Y-3.01%
MAMA Yearly Profit, Operating, Gross MarginsMAMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MAMA is creating some value.
Compared to 5 years ago, MAMA has more shares outstanding
MAMA Yearly Shares OutstandingMAMA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M
MAMA Yearly Total Debt VS Total AssetsMAMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 10M 20M 30M 40M

2.2 Solvency

MAMA has an Altman-Z score of 10.01. This indicates that MAMA is financially healthy and has little risk of bankruptcy at the moment.
MAMA's Altman-Z score of 10.01 is amongst the best of the industry. MAMA outperforms 95.60% of its industry peers.
MAMA has a debt to FCF ratio of 1.99. This is a very positive value and a sign of high solvency as it would only need 1.99 years to pay back of all of its debts.
The Debt to FCF ratio of MAMA (1.99) is better than 85.71% of its industry peers.
MAMA has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.07, MAMA is in the better half of the industry, outperforming 73.63% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.99
Altman-Z 10.01
ROIC/WACC1.28
WACC10.16%
MAMA Yearly LT Debt VS Equity VS FCFMAMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M 20M

2.3 Liquidity

MAMA has a Current Ratio of 1.29. This is a normal value and indicates that MAMA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.29, MAMA is doing worse than 63.74% of the companies in the same industry.
A Quick Ratio of 1.01 indicates that MAMA should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.01, MAMA perfoms like the industry average, outperforming 59.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.01
MAMA Yearly Current Assets VS Current LiabilitesMAMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2025 5M 10M 15M 20M

7

3. Growth

3.1 Past

MAMA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -26.67%.
MAMA shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.61% yearly.
MAMA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.04%.
MAMA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 29.59% yearly.
EPS 1Y (TTM)-26.67%
EPS 3YN/A
EPS 5Y17.61%
EPS Q2Q%200%
Revenue 1Y (TTM)17.04%
Revenue growth 3Y37.85%
Revenue growth 5Y29.59%
Sales Q2Q%18.15%

3.2 Future

MAMA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 68.33% yearly.
The Revenue is expected to grow by 13.60% on average over the next years. This is quite good.
EPS Next Y85.11%
EPS Next 2Y68.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.36%
Revenue Next 2Y13.6%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
MAMA Yearly Revenue VS EstimatesMAMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
MAMA Yearly EPS VS EstimatesMAMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 75.45, which means the current valuation is very expensive for MAMA.
MAMA's Price/Earnings ratio is in line with the industry average.
MAMA is valuated expensively when we compare the Price/Earnings ratio to 27.15, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 32.55, the valuation of MAMA can be described as expensive.
MAMA's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.60. MAMA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 75.45
Fwd PE 32.55
MAMA Price Earnings VS Forward Price EarningsMAMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

63.74% of the companies in the same industry are cheaper than MAMA, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MAMA is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 102.29
EV/EBITDA 33.42
MAMA Per share dataMAMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MAMA's earnings are expected to grow with 68.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)4.29
EPS Next 2Y68.33%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

MAMA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MAMA'S CREATIONS INC

NASDAQ:MAMA (6/30/2025, 8:00:01 PM)

After market: 8.3 0 (0%)

8.3

+0.08 (+0.97%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)06-03 2025-06-03/amc
Earnings (Next)09-08 2025-09-08
Inst Owners74.04%
Inst Owner ChangeN/A
Ins Owners4.3%
Ins Owner Change3.1%
Market Cap312.08M
Analysts82
Price Target10.54 (26.99%)
Short Float %5.93%
Short Ratio6.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.78%
Min EPS beat(2)6.95%
Max EPS beat(2)42.6%
EPS beat(4)3
Avg EPS beat(4)-1.66%
Min EPS beat(4)-73.86%
Max EPS beat(4)42.6%
EPS beat(8)6
Avg EPS beat(8)12.27%
EPS beat(12)9
Avg EPS beat(12)51.43%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.86%
Min Revenue beat(2)5.57%
Max Revenue beat(2)6.15%
Revenue beat(4)3
Avg Revenue beat(4)3.36%
Min Revenue beat(4)-1.14%
Max Revenue beat(4)6.15%
Revenue beat(8)7
Avg Revenue beat(8)4.77%
Revenue beat(12)10
Avg Revenue beat(12)3.93%
Revenue beat(16)13
Avg Revenue beat(16)3.25%
PT rev (1m)-6.06%
PT rev (3m)-6.06%
EPS NQ rev (1m)-26.67%
EPS NQ rev (3m)-26.67%
EPS NY rev (1m)-6.67%
EPS NY rev (3m)-10.5%
Revenue NQ rev (1m)1.57%
Revenue NQ rev (3m)1.39%
Revenue NY rev (1m)3.21%
Revenue NY rev (3m)3.86%
Valuation
Industry RankSector Rank
PE 75.45
Fwd PE 32.55
P/S 2.42
P/FCF 102.29
P/OCF 41.38
P/B 11.8
P/tB 21.18
EV/EBITDA 33.42
EPS(TTM)0.11
EY1.33%
EPS(NY)0.26
Fwd EY3.07%
FCF(TTM)0.08
FCFY0.98%
OCF(TTM)0.2
OCFY2.42%
SpS3.42
BVpS0.7
TBVpS0.39
PEG (NY)0.89
PEG (5Y)4.29
Profitability
Industry RankSector Rank
ROA 8.34%
ROE 16.62%
ROCE 16.71%
ROIC 12.98%
ROICexc 20.07%
ROICexgc 42.87%
OM 4.41%
PM (TTM) 3.41%
GM 24.39%
FCFM 2.37%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y219.36%
ROICexcg growth 5Y-6.93%
ROICexc growth 3Y244.9%
ROICexc growth 5Y-16.03%
OM growth 3Y185.5%
OM growth 5Y-8.49%
PM growth 3YN/A
PM growth 5Y-7.87%
GM growth 3Y0.31%
GM growth 5Y-3.01%
F-Score5
Asset Turnover2.44
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 1.99
Debt/EBITDA 0.22
Cap/Depr 132.57%
Cap/Sales 3.49%
Interest Coverage 14.38
Cash Conversion 83.15%
Profit Quality 69.42%
Current Ratio 1.29
Quick Ratio 1.01
Altman-Z 10.01
F-Score5
WACC10.16%
ROIC/WACC1.28
Cap/Depr(3y)80.56%
Cap/Depr(5y)82.95%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.69%
Profit Quality(3y)128.45%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-26.67%
EPS 3YN/A
EPS 5Y17.61%
EPS Q2Q%200%
EPS Next Y85.11%
EPS Next 2Y68.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)17.04%
Revenue growth 3Y37.85%
Revenue growth 5Y29.59%
Sales Q2Q%18.15%
Revenue Next Year17.36%
Revenue Next 2Y13.6%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.45%
EBIT growth 3Y293.57%
EBIT growth 5Y18.58%
EBIT Next Year200.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-61.33%
FCF growth 3Y17.93%
FCF growth 5Y-44.38%
OCF growth 1Y-10.86%
OCF growth 3Y78.52%
OCF growth 5Y23.39%